{
    "nct_id": "NCT03911700",
    "official_title": "Prospective, Multi-Center, Open-Label, Randomized, Controlled Trial of Phasix™ Mesh to Prevent Incisional Hernia Subsequent to Open Midline Laparotomy",
    "inclusion_criteria": "1. Must be ≥ 18 years of age\n2. Elective, open midline laparotomy ≥ 5 cm\n3. Willing and able to provide written informed consent\n4. Hernia risk equal to moderate or greater\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Previous hernia repair\n2. Emergent surgery\n3. Creation of skin flaps is preplanned\n4. Preplanned 2nd surgery\n5. Active skin pathology\n6. Life expectancy less than 36 months\n7. Pregnant or planning to become pregnant\n8. Receiving a medication/medical condition that may adversely affect wound healing\n9. ASA Class > IV\n10. Enrolled in another clinical trial\n11. Site personnel directly involved with this trial\n12. Any condition that would preclude the use of the device or the subject form completing the follow-up requirements\n13. Known or suspected allergy to tetracycline hydrochloride or kanamycin sulfate\n14. Two separate incisions are created\n15. Prior onlay mesh\n16. Surgeon is unable to fully close the fascia\n17. The surgery requires more than a single piece of mesh\n18. Contraindication to placement of mesh\n19. CDC Class IV/Active Infection\n20. Breastfeeding",
    "miscellaneous_criteria": ""
}